DRNA - Dicerna Pharmaceuticals Stock Trading

Dicerna Pharmaceuticals Inc.(NASDAQ: DRNA) stock trading, description, contact, officers and directors.

About Dicerna Pharmaceuticals Inc.

Not available

Stock Information

Dicerna Pharmaceuticals Inc. Company Name:

DRNA Stock Symbol:

NASDAQ Market:

DRNA - Dicerna Pharmaceuticals Stock Trading

Get DRNA Alerts

News, Short Squeeze, Breakout and More Instantly...

DRNA - Dicerna to Report Second Quarter 2021 Financial Results on Aug. 9, 2021

Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that the Company will release its second quarter 2021 financial results be...
DRNA - Dicerna Announces FDA Clearance of Investigational New Drug (IND) Application for DCR-AUD for the Treatment of Alcohol Use Disorder

– Novel ALDH2- Targeting GalXC™ RNAi Candidate Designed to Address a Highly Prevalent and Undertreated Disorder 1 – – Dicerna Expects to Initiate Phase 1 Clinical Trial of DCR-AUD in the Third Quarter of 2021 – Dicerna...
DRNA - Dicerna Announces Interim Results From Phase 1 Trial of Belcesiran for Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease

– Interim Results From Phase 1 Study Enabled Initiation and First Patient Dosing in Phase 2 ESTRELLA Study, Which Is Currently Underway – Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading develo...